US › Healthcare

Cardio Diagnostics Holdings Inc (CDIO)

US · Healthcare · Biotechnology

$1.69-3.98%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$5,360

Revenue YoY

-28.3%

Net profit

$-1.5M

EPS

$-0.51

Net margin

-28,012.5%

Key statistics

Market cap

$5.2M

Forward P/E

0.0

P/B

0.77

Book value

$2.51

EPS (TTM)

$-2.91

52-week high

$7.91

52-week low

$0.97

50-day MA

$1.92

200-day MA

$2.14

Beta

2.24

Analyst view

with an average price target of $60.00.

Shareholding

Insiders

8.31%

Institutions

6.52%

Largest institutional holders

Fund	Stake
Renaissance Technologies Corp	1.66%
BlackRock Inc	1.17%
Geode Capital Management, LLC	0.89%
Vanguard Capital Management, LLC	0.68%
Citadel Advisors Llc	0.64%
XTX Topco Ltd	0.54%
Jane Street Group LLC	0.40%
State Street Corp	0.34%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cardio Diagnostics Holdings Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.